Settlement would resolve data-sharing claims
People who used the GoodRx website, app or service before April 20, 2024, may qualify for compensation under a proposed $32 million settlement. The agreement would resolve claims that GoodRx shared users’ health information with third parties through tracking tools.
The allegations were made in a 2023 complaint. Plaintiffs claimed that technology on GoodRx’s website and app transmitted information about users’ health conditions and medications to advertising partners without their consent. The complaint says the alleged conduct violated multiple state laws.
GoodRx is a prescription price comparison and telehealth service. The companies identified in the claims include Meta, Google and digital advertising firm Criteo. GoodRx has not admitted wrongdoing. It agreed to the settlement to resolve the allegations.
Court filings say information from roughly 54.8 million people was shared through GoodRx’s tracking tools. The proposed agreement would resolve claims against GoodRx and Criteo if the court grants final approval. Claims against Meta and Google are continuing separately, according to Open Class Actions.
Key dates and payment details
| Item | Details |
|---|---|
| Settlement fund | $32 million |
| Claim deadline | 11:59 p.m. Eastern time on Dec. 29, 2026 |
| Final approval hearing | Feb. 11, 2027 |
| Estimated individual payment | Not yet determined |
The amount each eligible claimant could receive has not been set. It will depend on the number of valid claims submitted. The attorneys representing the plaintiffs are seeking $10.67 million from the settlement fund for legal fees and expenses, or roughly one-third of the total.
The settlement website says eligible class members must submit a claim by Dec. 29, 2026. Forms may be submitted online or downloaded and mailed to the settlement administrator, GoodRx Data Disclosure Settlement c/o A.B. Data Ltd., P.O. Box 173138, Milwaukee, WI 53217.
Approval is still pending
The agreement is not final. The court has scheduled a final approval hearing for Feb. 11, 2027. A judge must approve the settlement before payments can be distributed and the covered claims against GoodRx and Criteo can be resolved.
The case concerns alleged use of tracking technology to send sensitive information to advertising companies. The claims do not establish that every person whose information was collected suffered the same harm, and the proposed payment will depend on the final number of approved claims. Meta and Google remain defendants in separate claims tied to the alleged data sharing.
- Potential class members include people who used GoodRx before April 20, 2024.
- Claims must be submitted by 11:59 p.m. Eastern time on Dec. 29, 2026.
- The settlement remains subject to final court approval at a Feb. 11, 2027, hearing.
